TransEnterix (NYSE:TRXC) is planning for an upcoming $75 million offering, according to a recently posted SEC filing.
The Research Triangle Park, N.C.-based company said that Stifel, Nicolaus & Company will serve as its sale agent in the offering, but the company has not yet announced how many shares it plans to float in the sale.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,